JUBLINGREA Share Price Performance
₹0
-823.35 (-100.00%)
Price ₹0
Fair Value₹987.75
Share Pricen/a
Narrative Update • Jul 13
Jubilant Ingrevia Limited Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 6 Fair Values set on narratives written by author
JUBLINGREA Community Narratives
AN
Fair Value
·Fair Value ₹987.75 25.4% undervalued intrinsic discount
Improved Margins And Board Meeting Will Shape Export Opportunity Outlook
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
Fair Value
·Fair Value ₹1.15k 35.9% undervalued intrinsic discount
Rising Green Chemistry Demand Will Reimagine Global Specialty Markets
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
Fair Value
·Fair Value ₹705 4.5% overvalued intrinsic discount
Regulatory Tensions And China+1 Shifts Will Test Recovery Prospects
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Regulatory Tensions And China+1 Shifts Will Test Recovery Prospects
Jubilant Ingrevia looks set to gain from customers shifting sourcing toward India and rising demand for more specialized, cleaner chemical ingredients, but tighter rules and changing trade politics could quickly turn that tailwind into a headwind. Heavy spending on new capacity and reliance on a handful of key products mean any slowdown in demand, pricing pressure, or new production technology could hit results harder than many expect.Read more
AN
₹705
4.5% overvalued intrinsic discount
Fair Value
Revenue
16.15% p.a.
Profit Margin
9.55%
Future PE
24.18x
Price in 2029
₹1.01k
Rising Green Chemistry Demand Will Reimagine Global Specialty Markets
Jubilant Ingrevia is ramping up new plants and a growing lineup of specialty products that could help it win more business as global customers look for reliable, compliant suppliers. But its results can still swing with basic chemical prices and rising regulatory costs, so the path to stronger profits may not be smooth.Read more
AN
₹1.15k
35.9% undervalued intrinsic discount
Fair Value
Revenue
18.68% p.a.
Profit Margin
8.88%
Future PE
39.82x
Price in 2029
₹1.64k
Improved Margins And Board Meeting Will Shape Export Opportunity Outlook
Key Takeaways Expansion in specialty chemicals and nutrition, combined with new export opportunities and supply chain shifts, is fueling sustained growth and higher-margin revenues. Strategic investments, cost optimization, and backward integration are strengthening profitability and supporting the company's shift toward more resilient, value-added business segments.Read more
AN
₹987.75
25.4% undervalued intrinsic discount
Fair Value
Revenue
15.82% p.a.
Profit Margin
9.39%
Future PE
36.48x
Price in 2028
₹1.44k
Trending Discussion
No trending discussion available.
Recently Updated Narratives
AN
JUBLINGREA: Upcoming Board Decisions May Temper But Sustain Current Optimism
Fair Value: ₹705 4.5% overvalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
JUBLINGREA: Upcoming Board Meeting And Dividend Decision Will Support Long Term Earnings Visibility
Fair Value: ₹1.15k 35.9% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
JUBLINGREA: Solid Revenue Outlook And Profitable Operations Will Boost Future Upside
Fair Value: ₹987.75 25.4% undervalued intrinsic discount
2 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Jubilant Ingrevia Limited Key Details
Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Jul 22, 2026
- 17.58
- 38.18%
- 6.33%
- 25.0%
About JUBLINGREA
- Founded
- 2019
- Employees
- 2139
- CEO
- WebsiteView website
Jubilant Ingrevia Limited engages in life science products and solutions in India, the United States, Europe, China and internationally. The company operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates. The Specialty Chemicals segment offers bio-pyridine and -picolines, fine chemicals, agro chemicals, custom development and manufacturing services, and microbial control solutions. The Nutrition & Health Solutions segment provides nutrition and health ingredients; and animal and human nutrition health solutions. The Chemical intermediates segment offers acetyls and specialty ethanol. In addition, it provides vitamins, mineral premixes, stress regulator, amino acid, herbal choline, herbal non-antibiotic growth promoter and egg quality enhancer, toxin binder, acidifiers, and enzymes and emulsifiers. The company serves pharmaceutical, nutrition, agrochemical, consumer, and industrial sectors. The company was formerly known as Jubilant LSI Limited and changed its name to Jubilant Ingrevia Limited in October 2020. Jubilant Ingrevia Limited was incorporated in 2019 and is headquartered in Noida, India.
Recent JUBLINGREA News & Updates
Narrative Update • Jun 15
